Bradshaw Start free trial

Revela Health Limited

Active

Data to 4 Nov 2026, 02:03

Company number
15171762
Sector
Health and life sciences
SIC group
Software and IT
Region
North East (Newcastle Upon Tyne)
Incorporated
28 Sep 2023
SIC code
63110
Trading name
Not found
Website
Not found

Revela Health Limited has 1 priced round on record from share allotment filings at Companies House. The latest was allotted on 17 Dec 2025, raised £241k, and was filed on 20 Jan 2026. Data to 3 Nov 2026.

1

Priced rounds

Allotted Dec 2025

£241k

Cash raised in those rounds

Sum of sterling cash raised in each round, as filed

17 Dec 2025

Latest round allotted

Filed 20 Jan 2026

Jump to

Funding rounds

Priced equity rounds read from share allotment filings at Companies House, newest first.

Edit columns
Funding rounds for Revela Health Limited
Allotted First filed Cash raised Filing
17 Dec 2025Latest 20 Jan 2026 £241k Open filing
Price per share, post-money and step-ups for this round are in the full company page.

Companies with significant control

Companies with significant control over Revela Health Limited, from the register of people with significant control. A company can have control without holding shares. Individuals are not shown on public pages.

No corporate holder of 25% or more is registered.

From the PSC register.

Filings

The latest 2 capital filings other than share allotments (SH01), which are listed under Funding rounds. 2 share filings (SH01 and SH02) have been read for this company.

Edit columns
Latest capital filings
Date Filing Document
9 May 2025 Resolution Open at Companies House
8 Oct 2024 Subdivision or consolidation of shares (SH02) Open at Companies House

Documents open at Companies House. Bradshaw does not store or re-host them.

About this page

This page shows public register data for Revela Health Limited. Figures come from filings at Companies House; Bradshaw links to each filing and does not host copies. To correct or object to data about you, use the data request form.

Last updated 3 Nov 2026